Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - mucopolysaccharide polysulfate 0,3 g/100 g - gel - 300 mg/100 g - mucopolysaccharide polysulfate 3 mg/g - organo-heparinoid

Kenya - English - Pharmacy and Poisons Board

daiichi sankyo europe gmbh zielstattstrasse 48… zielstattstrasse 48 81379 munich germany - mucopolysaccharide polysulfate - gel - 300mg/100g - organo-heparinoid

Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

مستودع أدوية أداتكو - adatco drug store - sugammadex 100 mg/ml - 100 mg/ml

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - heparin sodium -

Australia - English - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - heparin sodium -

Australia - English - Department of Health (Therapeutic Goods Administration)

heparin sodium -

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - heparin sodium, quantity: 5000 iu/ml - injection, solution - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide - indications as at 26 november 2001: prophylaxis and treatment of thromboembolic disorders such as thrombophlebitis, pulmonary embolism, coronary or venous thrombosis and occlusive vascular disease. as a low-dose regimen for the prevention of thromboembolic complications arising as a result of cardiac and arterial surgery. as an anticoagulant during blood transfusions, extracorporeal circulation, dialysis and other perfusion techniques and in blood samples for laboratory purposes.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - heparin sodium, quantity: 1000 iu/ml - injection, solution - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide - indications as at 26 november 2001: prophylaxis and treatment of thromboembolic disorders such as thrombophlebitis, pulmonary embolism, coronary or venous thrombosis and occlusive vascular disease. as a low-dose regimen for the prevention of thromboembolic complications arising as a result of cardiac and arterial surgery. as an anticoagulant during blood transfusions, extracorporeal circulation, dialysis and other perfusion techniques and in blood samples for laboratory purposes.

Australia - English - Department of Health (Therapeutic Goods Administration)

stallergenes australia pty ltd - white shrimp -

Australia - English - Department of Health (Therapeutic Goods Administration)

stallergenes australia pty ltd - secale cereale -